Doctor profile · Federal record
Dr. MATTHEW BEAL, MD
Dermatology Physician (CMS: DERMATOLOGY) · Student in an Organized Health Care Education/Training Program · TUCSON, AZ
- NPI 1881913846
- Accepts Medicare
- MIPS 71.0 / 100 · 2023
- 17 yrs in practice
- Male
- Solo practice
- No sanctions
Practice & contact
- Primary practice
-
5150 E GLENN ST
TUCSON, AZ 857121337
(520) 795-7729
fax (520) 795-4177
Credentials & registration
- NPI registered
- May 2010 — 16 yrs on file
- Profile last updated
- September 17, 2020
- Year of graduation
- 2009 — 17 yrs since
- Specialty taxonomy
- 207N00000X — NUCC code
- State license (1)
- Arizona #47563
- Medicaid
- AZ #838508
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1881913846. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
13,380
Distinct HCPCS
10
Medicare allowed
$501,104
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
17003 |
Destruction of precancer skin growth, 2-14 growths | 4,911 | 610 | $6 | |
J7345 |
Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg | 3,200 | 15 | $2 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 1,468 | 970 | $88 | |
17000 |
Destruction of precancer skin growth, 1 growth | 1,113 | 743 | $43 | |
11102 |
Biopsy of related skin growth, first growth | 958 | 712 | $93 | |
17110 |
Destruction of skin growth, 1-14 growths | 263 | 223 | $105 | |
17262 |
Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | 233 | 195 | $162 | |
11103 |
Biopsy of related skin growth, each additional growth | 202 | 170 | $49 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 178 | 163 | $124 | |
99212 |
Established patient office or other outpatient visit, 10-19 minutes | 161 | 153 | $55 |
In context: peer comparison
Among 17 peers in this city , average services per provider: 310. This provider delivers 43× the peer median.Open Payments
Industry payments received
All-time total
$1,202
Transactions
54
Manufacturers
13
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| GENZYME CORPORATION | 12 | $353.09 | |
| ABBVIE INC. | 20 | $346.52 | |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $83.92 | |
| LEO Pharma Inc. | 2 | $63.04 | |
| Novartis Pharmaceuticals Corporation | 2 | $56.07 | |
| Regeneron Healthcare Solutions, Inc. | 2 | $55.32 | |
| Lilly USA, LLC | 2 | $55.21 | |
| UCB, Inc. | 2 | $53.32 | |
| Amgen Inc. | 2 | $43.88 | |
| PFIZER INC. | 3 | $39.92 | |
| Arcutis Biotherapeutics, Inc. | 1 | $21.13 | |
| Janssen Biotech, Inc. | 1 | $15.80 | |
| Galderma Laboratories, L.P. | 1 | $14.80 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
958
Patients
601
Total drug cost
$254,970
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Triamcinolone Acetonide | Generic | 221 | 156 | $2,560 |
| Ketoconazole | Generic | 136 | 85 | $2,761 |
| Clobetasol Propionate | Generic | 129 | 94 | $5,352 |
| Doxycycline Hyclate | Generic | 82 | 57 | $2,633 |
| Valacyclovir (Valacyclovir Hcl) | Brand | 68 | 40 | $1,991 |
| Hydrocortisone | Generic | 64 | 46 | $375 |
| Fluorouracil | Generic | 39 | 31 | $2,399 |
| Dupixent Pen (Dupilumab) | Brand | 35 | 0 | $132,672 |
| Mupirocin | Generic | 33 | 30 | $270 |
| Prednisone | Generic | 30 | 26 | $87 |